微血管和宏血管疾病与减肥手术后糖尿病缓解之间的关联
Wissam Ghusn1,2, Marita Salame3, Lea Sayegh1
1Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Surgical endoscopy
|February 2, 2024
概括
在患有先前存在的血管并发症的患者中,胃绕道手术后的2型糖尿病 (T2DM) 缓解的可能性较小. 这些与糖尿病相关的疾病的数量显著影响了缓解率,有助于患者管理.
科学领域:
- 代谢手术 代谢手术
- 内分泌学 在内分泌学.
- 糖尿病的血管并发症
背景情况:
- 2型糖尿病 (T2DM) 与显著的微血管和宏血管并发症有关.
- 鲁克斯-en-Y胃绕道 (RYGB) 和袖子胃切除术 (SG) 是T2DM缓解的有效减肥手术.
- 关于先前存在的糖尿病相关疾病如何影响RYGB和SG后的缓解率的数据有限.
研究的目的:
- 调查糖尿病手术前微血管和宏血管并发症与RYGB和SG后T2DM缓解之间的关联.
- 评估这些先前存在的条件对缓解的累积影响.
- 为了确定T2DM缓解的预测因子在减肥手术后.
主要方法:
- 对536名T2DM患者进行了回顾性队列研究,这些患者接受了RYGB或SG.
- 收集了手术前微血管 (视网膜病,脏病,神经病) 和宏血管 (冠状动脉疾病,脑血管事故,外周动脉疾病) 疾病的数据.
- 多变量逻辑回归用于分析与T2DM缓解的关联.
主要成果:
- 没有糖尿病相关疾病的患者的T2DM缓解率 (OR2.72) 与患有疾病 (27.9%vs59.4%缓解率) 相比显著更高.
- 观察到糖尿病相关疾病数量对T2DM缓解的附加效应 (p < 0.001).
- 缓解的重要预测因素包括HbA1c,糖尿病药物的数量,T2DM持续时间,手术类型和胰岛素使用.
结论:
- 手术前的糖尿病相关疾病与RYGB和SG后的T2DM缓解率较低有关.
- 这些并发症是T2DM缓解的实际预测因素.
- 识别患有先前并发症的患者可以为更严重的T2DM病例提供多学科管理策略.
相关概念视频
Pathophysiology of Diabetes
940
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
940
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes: Symptoms, Diagnosis, and Complications
544
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
544
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Oral Hypoglycemic Agents: Biguanides and Glitazones
204
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
204


